Clinical Trial Update: Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating gene-guided N-acetylcysteine to prevent anti-tuberculosis drug-induced hepatitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Mahidol University | Conditions: Tuberculosis (TB), Isoniazid Toxicity | Phase 4 | Status: RECRUITING